Activity Provided By:

Relias LLC

DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We and Where Are We Going?

Overview / Abstract:	Target Audience This educational program is directed toward cardiologists and cardiology subspecialists involved in the care of patients with or at risk for atherosclerotic disease. Nurse practitioners, physician assistants, nurses, and other health care professionals interested in the treatment of atherosclerotic disease are invited to participate. Activity Overview Effective management of high-risk patients with coronary artery disease (CAD) and peripheral artery disease (PAD) is essential for decreasing major adverse events such as myocardial infarction, stroke, limb amputations, and death. Recent studies evaluating antithrombotic strategies such as dual antiplatelet therapy and dual pathway inhibition (DPI) have shown that DPI is an effective strategy in reducing these major adverse events in high-risk patients. This Community Practice Connections™ program provides an in-depth review of some of the key highlights from the satellite symposium Cases and Conversations™: Making the Most of Effective Antithrombotic Strategies in Patients with CAD and PAD, presented at the 2021 American Heart Association Annual Scientific Sessions. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with CAD and PAD, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did. Learning Objectives Upon completion of this activity, you should be better able to: Discuss the pathophysiology of atherosclerosis -Describe the rationale for novel secondary prevention antithrombotic strategies in high-risk patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD) -Evaluate the efficacy and safety of antithrombotic strategies in patients with CAD and/or PAD to mitigate cardiovascular risk -Develop strategies to overcome challenges in reducing the risk of secondary events in patients with PAD and/or CAD
Expiration	Dec 22, 2022
Discipline(s)	Physician CME
Format	Online
Credits / Hours	1.0
Accreditation	ACCME
Presenters / Authors / Faculty	Kelley Robert Branch, MD, MS Professor of Medicine Director, Cardiovascular Clinical Trials Associate Director, Clinical Trials Service Unit UW School of Medicine Attending Physician University of Washington Medical Center Seattle, WA Sonia Anand, MD, PhD Professor of Medicine and Epidemiology Tier 1 Canada Research Chair Director, Population Genomics Program HSF/Michael G. DeGroote Chair in Population Health Research McMaster University Hamilton, Ontario, Canada Schuyler Jones, MD Associate Professor of Medicine and Population Health Sciences Medical Director, Duke Heart Center Clinical Research Unit Director, Duke University Cardiac Catheterization Laboratory Duke University School of Medicine Durham, NC Christian Thomas Ruff, MD, MPH Associate Professor of Medicine Harvard Medical School Director, General Cardiology, Cardiovascular Division Brigham and Women’s Hospital Boston, MA
Sponsors / Supporters / Grant Providers	Physicians’ Education Resource®, LLC.; Janssen Pharmaceuticals, Inc.,; Janssen Scientific Affairs, LLC.
Keywords / Search Terms	Relias LLC Cardiology, Primary Care, Cardiovascular Disease, Heart Disease Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map